Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.058 | 0.3 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.3 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.3 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |